MORGAN STANLEY PLC/CALL/CVS HEALTH/92/0.1/20.12.24 Share Price

Warrant

DE000MB33TA9

Market Closed - Börse Stuttgart 12:03:58 04/07/2024 am IST
0.031 EUR -13.89% Intraday chart for MORGAN STANLEY PLC/CALL/CVS HEALTH/92/0.1/20.12.24
Current month-16.22%
1 month-18.42%
Date Price Change
03/24/03 0.031 -13.89%
02/24/02 0.036 0.00%
01/24/01 0.036 -2.70%
28/24/28 0.037 +2.78%
27/24/27 0.036 -7.69%

Delayed Quote Börse Stuttgart

Last update July 04, 2024 at 12:03 am IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying CVS HEALTH CORPORATION
Issuer Morgan Stanley
WKN MB33TA
ISINDE000MB33TA9
Date issued 01/02/2023
Strike 92 $
Maturity 20/12/2024 (170 Days)
Parity 10 : 1
Emission price 1.15
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.23
Lowest since issue 0.019
Spread 0.009
Spread %22.50%

Company Profile

CVS Health Corporation is one of the leading American suppliers of health products and services. Net sales (including intragroup) break down by activity as follows: - medical insurance plan management services (45.6%; Pharmacy Benefit Management): administrative management (reimbursement management, patient claim processing, etc.), drug distribution, decision-making information, sales of medical information management services, etc.; - retail distribution (28.5%): sale of prescription pharmaceutical products, OTC products, beauty and cosmetics products. At the end of 2023, products are marketed primarily via a network of more than 9,000 outlets and via the Internet. In addition, the group offers healthcare services through more than 1,000 clinics (MinuteClinic®); - medical benefits management (25.8%); - other (0.1%).
Sector
-
More about the company

Ratings for CVS Health Corporation

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: CVS Health Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
56.7 USD
Average target price
69.1 USD
Spread / Average Target
+21.86%
Consensus